196 related articles for article (PubMed ID: 32699065)
21. Loss of heterozygosity at 2q37 in sporadic Wilms' tumor: putative role for miR-562.
Drake KM; Ruteshouser EC; Natrajan R; Harbor P; Wegert J; Gessler M; Pritchard-Jones K; Grundy P; Dome J; Huff V; Jones C; Aldred MA
Clin Cancer Res; 2009 Oct; 15(19):5985-92. PubMed ID: 19789318
[TBL] [Abstract][Full Text] [Related]
22. Identical genetic changes in different histologic components of Wilms' tumors.
Zhuang Z; Merino MJ; Vortmeyer AO; Bryant B; Lash AE; Wang C; Deavers MT; Shelton WF; Kapur S; Chandra RS
J Natl Cancer Inst; 1997 Aug; 89(15):1148-52. PubMed ID: 9262253
[TBL] [Abstract][Full Text] [Related]
23. TRIM28 inactivation in epithelial nephroblastoma is frequent and often associated with predisposing TRIM28 germline variants.
Wegert J; Fischer AK; Palhazi B; Treger TD; Hilgers C; Ziegler B; Jung H; Jüttner E; Waha A; Fuchs J; Warmann SW; Frühwald MC; Hubertus J; Pritchard-Jones K; Graf N; Behjati S; Furtwängler R; Gessler M; Vokuhl C
J Pathol; 2024 Jan; 262(1):10-21. PubMed ID: 37792584
[TBL] [Abstract][Full Text] [Related]
24. Convergent evolution of 11p allelic loss in multifocal Wilms tumors arising in WT1 mutation carriers.
Valind A; Wessman S; Pal N; Karlsson J; Jonson T; Sandstedt B; Gisselsson D
Pediatr Blood Cancer; 2018 Nov; 65(11):e27301. PubMed ID: 29968962
[TBL] [Abstract][Full Text] [Related]
25. Isochromosome 7q in adult Wilms' tumors: diagnostic and pathogenetic implications.
Rubin BP; Pins MR; Nielsen GP; Rosen S; Hsi BL; Fletcher JA; Renshaw AA
Am J Surg Pathol; 2000 Dec; 24(12):1663-9. PubMed ID: 11117788
[TBL] [Abstract][Full Text] [Related]
26. A common region of loss of heterozygosity in Wilms' tumor and embryonal rhabdomyosarcoma distal to the D11S988 locus on chromosome 11p15.5.
Besnard-Guérin C; Newsham I; Winqvist R; Cavenee WK
Hum Genet; 1996 Feb; 97(2):163-70. PubMed ID: 8566947
[TBL] [Abstract][Full Text] [Related]
27. A novel WT1 gene mutation associated with wilms' tumor and congenital male genitourinary malformation.
Sakamoto J; Takata A; Fukuzawa R; Kikuchi H; Sugiyama M; Kanamori Y; Hashizume K; Hata JI
Pediatr Res; 2001 Sep; 50(3):337-44. PubMed ID: 11518820
[TBL] [Abstract][Full Text] [Related]
28. Correlation of chromosome abnormalities with histological and clinical features in Wilms' and other childhood renal tumors.
Kaneko Y; Homma C; Maseki N; Sakurai M; Hata J
Cancer Res; 1991 Nov; 51(21):5937-42. PubMed ID: 1657374
[TBL] [Abstract][Full Text] [Related]
29. Loss of allelic heterozygosity at a second locus on chromosome 11 in sporadic Wilms' tumor cells.
Reeve AE; Sih SA; Raizis AM; Feinberg AP
Mol Cell Biol; 1989 Apr; 9(4):1799-803. PubMed ID: 2542777
[TBL] [Abstract][Full Text] [Related]
30. Clinical, pathological and loss of heterozygosity differences in Wilms tumors between Asian and non-Asian children.
Loke BN; Wong MK; Tawng KD; Kuick CH; Jain S; Lian D; Wagner E; Zou Y; Ganesan V; Sim SW; Lee YT; Chin F; Chan MY; Tan AM; Teh BT; Soh SY; Chang KTE; Loh AHP
Int J Cancer; 2019 Mar; 144(6):1234-1242. PubMed ID: 30362502
[TBL] [Abstract][Full Text] [Related]
31. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.
Park S; Bernard A; Bove KE; Sens DA; Hazen-Martin DJ; Garvin AJ; Haber DA
Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644
[TBL] [Abstract][Full Text] [Related]
32. The G401 cell line, utilized for studies of chromosomal changes in Wilms' tumor, is derived from a rhabdoid tumor of the kidney.
Garvin AJ; Re GG; Tarnowski BI; Hazen-Martin DJ; Sens DA
Am J Pathol; 1993 Feb; 142(2):375-80. PubMed ID: 8382007
[TBL] [Abstract][Full Text] [Related]
33. Cytogenetic abnormalities in mesoblastic nephroma: a link to Wilms' tumour?
Roberts P; Lockwood LR; Lewis IJ; Bailey CC; Batcup G; Williams J
Med Pediatr Oncol; 1993; 21(6):416-20. PubMed ID: 8390601
[TBL] [Abstract][Full Text] [Related]
34. The familial Wilms' tumour susceptibility gene, FWT1, may not be a tumour suppressor gene.
Rahman N; Arbour L; Tonin P; Baruchel S; Pritchard-Jones K; Narod SA; Stratton MR
Oncogene; 1997 Jun; 14(25):3099-102. PubMed ID: 9223674
[TBL] [Abstract][Full Text] [Related]
35. Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome 11 in Wilms' tumours.
Mannens M; Slater RM; Heyting C; Bliek J; de Kraker J; Coad N; de Pagter-Holthuizen P; Pearson PL
Hum Genet; 1988 Dec; 81(1):41-8. PubMed ID: 2848758
[TBL] [Abstract][Full Text] [Related]
36. Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.
Gessler M; König A; Arden K; Grundy P; Orkin S; Sallan S; Peters C; Ruyle S; Mandell J; Li F
Hum Mutat; 1994; 3(3):212-22. PubMed ID: 8019557
[TBL] [Abstract][Full Text] [Related]
37. Wilms' tumour as a paradigm for the relationship of cancer to development.
Pritchard-Jones K; Hastie ND
Cancer Surv; 1990; 9(3):555-78. PubMed ID: 1966278
[TBL] [Abstract][Full Text] [Related]
38. Molecular genetics of Wilms' tumour.
Tay JS
J Paediatr Child Health; 1995 Oct; 31(5):379-83. PubMed ID: 8554853
[TBL] [Abstract][Full Text] [Related]
39. Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children's Oncology Group AREN18B5-Q.
Murphy AJ; Cheng C; Williams J; Shaw TI; Pinto EM; Dieseldorff-Jones K; Brzezinski J; Renfro LA; Tornwall B; Huff V; Hong AL; Mullen EA; Crompton B; Dome JS; Fernandez CV; Geller JI; Ehrlich PF; Mulder H; Oak N; Maciezsek J; Jablonowski CM; Fleming AM; Pichavaram P; Morton CL; Easton J; Nichols KE; Clay MR; Santiago T; Zhang J; Yang J; Zambetti GP; Wang Z; Davidoff AM; Chen X
Nat Commun; 2023 Dec; 14(1):8006. PubMed ID: 38110397
[TBL] [Abstract][Full Text] [Related]
40. Subtype-specific FBXW7 mutation and MYCN copy number gain in Wilms' tumor.
Williams RD; Al-Saadi R; Chagtai T; Popov S; Messahel B; Sebire N; Gessler M; Wegert J; Graf N; Leuschner I; Hubank M; Jones C; Vujanic G; Pritchard-Jones K; ;
Clin Cancer Res; 2010 Apr; 16(7):2036-45. PubMed ID: 20332316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
